Rapid Dose Therapeutics logo

DOSE - Rapid Dose Therapeutics News Story

C$0.24 0.0  0.0%

Last Trade - 05/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £10.8m
Enterprise Value £11.7m
Revenue £112k
Position in Universe 1669th / 2701

Rapid Dose Therapeutics Announces Grant of Incentive Stock Options and the Issuance of Warrants

Tue 30th March, 2021 10:44pm
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210330:nGNX7tQ7nL&default-theme=true


BURLINGTON, Ontario, March 30, 2021 (GLOBE NEWSWIRE) -- Rapid Dose
Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE)
(https://www.globenewswire.com/Tracker?data=bzrl4CufB1T5xmdGLKNe6MrXgTxhh5GdGFyeYtMkif6W2U9TjrASe8E-GdN0oe7xIEF1yL0BWKFTqyh7DGSqGnI1nxI-uH-8vBNe4ChnSCqGj7nNplNCWbBqEbwbd0SYydM6WDZOl2kYhK-GCpu_RQ==),
announces, pursuant to its Stock Option Plan, the granting of incentive stock
options to purchase 4,490,000 common shares at an exercise price of $0.24 per
share. Each has a term of 2 years and vests equally every six months over the
term. The grant of options is subject to the policies, and acceptance by, the
Canadian Securities Exchange.

In addition, the Company announces, pursuant to an advisory agreement, the
issuance of 200,000 Share Purchase Warrants having an Exercise Price of $0.24
per share for a two year term ending March 28, 2023.

Further, the Company announces, pursuant to an investment and public relations
services agreement, the issuance of 200,000 Share Purchase Warrants having an
Exercise Price of $0.24 per share for a two year term ending March 28, 2023.

About RDT

Rapid Dose Therapeutics Corp. is a publicly-traded Canadian life sciences
company providing innovative, proprietary drug delivery technologies designed
to improve outcomes and quality of lives. RDT offers Quick, Convenient,
Precise and Discreet™ choices to consumers. RDT is focused and committed to
clinical research and product development for the healthcare manufacturing
industry — including nutraceutical, pharmaceutical and cannabis industries.
RDT is committed to continually create innovative solutions for humans,
animals, and plants.

For more information, visit: www.rapiddose.ca

For inquiries please contact:

   Mark Upsdell             Pat McCarthy                       
   CEO                      Managing Director Capital Markets  
   mupsdell@rapid-dose.com  pmccarthy@leedejonesgable.com      
   Ofc (416) 477-1052       Ofc (416) 365-8012                 



(https://www.globenewswire.com/NewsRoom/AttachmentNg/a387d767-6399-4b6a-b8b1-63a75fef7963)



GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.